Denosumab Biosimilar, N297A Mutant
Denosumab Biosimilar, N297A Mutant. Denosumab biosimilar CHO stable cell line is available for licensing to manufacture the denosumab biosimilar protein.The research grade denosumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype...
